As of Sep 30
| +0.07 / +5.26%|
The 2 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +150.00% increase from the last price of 1.40.
The current consensus among 2 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.